Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI-Reference-Cited by-同舟云学术

Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI

Published:2019-02 Issue: Volume:205 Page:176-182
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Chan Min-Ju,Liao Hsuan-Chieh^ORCID,Gelb Michael H.,Chuang Chih-Kuang,Liu Mei-Ying,Chen Hsiao-Jan,Kao Shu-Min,Lin Hsiang-Yu,Huang You-Hsin,Kumar Arun Babu^ORCID,Chennamaneni Naveen Kumar,Pendem Nagendar,Lin Shuan-Pei,Chiang Chuan-Chi

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference46 articles.

1. The mucopolysaccharidoses (a review);Dorfman;Proc Natl Acad Sci USA,1976

2. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS;Byers;Mol Genet Metab,1998

3. Open issues in Mucopolysaccharidosis type I-Hurler;Parini;Orphanet J Rare Dis,2017

4. The clinical and genetic spectrum of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI) in the Eastern Province of Saudi Arabia;Al-Sannaa;J Commun Genet,2018

5. Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future;Whiteman;Drug Des Devel Ther,2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond;BioDrugs;2024-08-23

2. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023);International Journal of Neonatal Screening;2024-05-23

3. Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses;Orphanet Journal of Rare Diseases;2024-04-29

4. Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1/2 study;Molecular Genetics and Metabolism;2023-12

5. Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II;Molecular Genetics and Metabolism;2023-11